GF
ORTX

Gabelli Funds’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Gabelli Funds’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-224,250
Closed -$3.69M – 1153
2023
Q4 		$3.69M Buy
+224,250
New +$3.53M 0.03% 518

Gabelli Funds's ORTX Position: Q1 2024 in Review

Gabelli Funds sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 224,250 shares — an estimated $3.69M sold.

Gabelli Funds first reported a position in ORTX in Q4 2023 and held it in 1 quarter. The position peaked at $3.69M in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

  • Gabelli Funds reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Gabelli Funds sold 224,250 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $3.69M.
  • Gabelli Funds first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
  • Gabelli Funds's Orchard Therapeutics plc American Depositary Shares position peaked at $3.69M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Gabelli Funds's 13F filing for Q1 2024, filed 14 May 2024.